Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 906 entries
Sorted by: Best Match Show Resources per page
'I like the “outernet” stuff:'girls' perspectives on physical activity and their environments

after-school settings

Coen SE.
GSID: GDf3GcYVPR4J
SE Coen, CA Mitchell, S Tillmann… - Qualitative Research in …, 2019 - Taylor & Francis

Physical activity in Canada mirrors the gender gap observed globally, with boys more likely than girls to meet recommended guidelines. While a growing body of research has …

Cite
Coen, S. E., Mitchell, C. A., Tillmann, S., & Gilliland, J. A. (2019). ‘I like the “outernet” stuff:’girls’ perspectives on physical activity and their environments. Qualitative Research in Sport, Exercise and Health, 11(5), 599-617.
Coen, Stephanie E., et al. "‘I like the “outernet” stuff:’girls’ perspectives on physical activity and their environments." Qualitative Research in Sport, Exercise and Health 11.5 (2019): 599-617.
Copy Download .nbib Format: MLA
Group education interventions for people with low back pain. An overview of the literature

education interventions

Cohen JE, Frank JW.
GSID: EFku6D8y8osJ
JE Cohen, V Goel, JW Frank, C Bombardier, P Peloso… - Spine, 1994 - europepmc.org

… education for people with low back pain. Findings are considered in relation to parameters such as the characteristics of the study participants, the intervention, and the setting. OBJECTIVE:To make a recommendation regarding the effectiveness of group education as...

Cite
Cohen, J. E., Goel, V., Frank, J. W., Bombardier, C., Peloso, P., & Guillemin, F. (1994). Group education interventions for people with low back pain. An overview of the literature. Spine, 19(11), 1214-1222.
Cohen, Joanna E., et al. "Group education interventions for people with low back pain. An overview of the literature." Spine 19.11 (1994): 1214-1222.
Copy Download .nbib Format: MLA
Examining the Effects of Familial Occupations and Early STEM Experiences on Female Students' STEM Identity and Career Intentions

Stem career programs

Cohen SM.
GSID: skCppfT50mgJ
SM Cohen - 2020 - digitalcommons.fiu.edu

The studies within this collected papers dissertation investigate the effects of familial occupations and early experiences in STEM on female students' STEM identity and career intentions. The salience of this topic originates from the underrepresentation of women in STEM...

Cite
Cohen, S. M. (2020). Examining the Effects of Familial Occupations and Early STEM Experiences on Female Students' STEM Identity and Career Intentions.
Cohen, Susie M. "Examining the Effects of Familial Occupations and Early STEM Experiences on Female Students' STEM Identity and Career Intentions." (2020).
Copy Download .nbib Format: MLA
The role of theory-driven graphic warning labels in motivation to quit: a qualitative study on perceptions from low-income, urban smokers

socioeconomic status & related terms (e.g., low income)

Mead EL, Cohen JE, Kennedy CE.
GSID: 0Gv3TbCWLnQJ
EL Mead, JE Cohen, CE Kennedy… - BMC Public …, 2015 - bmcpublichealth.biomedcentral.com

… In the US, low socioeconomic status (SES) smokers are less … in low-income neighborhoods through street outreach and word-of-… For example, responses were summarized for all codes …

Cite
Mead, E. L., Cohen, J. E., Kennedy, C. E., Gallo, J., & Latkin, C. A. (2015). The role of theory-driven graphic warning labels in motivation to quit: a qualitative study on perceptions from low-income, urban smokers. BMC Public Health, 15(1), 1-11.
Mead, Erin L., et al. "The role of theory-driven graphic warning labels in motivation to quit: a qualitative study on perceptions from low-income, urban smokers." BMC Public Health 15.1 (2015): 1-11.
Copy Download .nbib Format: MLA
Tornado outbreak variability follows Taylor's power law of fluctuation scaling and increases dramatically with severity.

Nature communications

Tippett MK, Cohen JE.
PMID: 26923210
Nat Commun. 2016 Feb 29;7:10668. doi: 10.1038/ncomms10668.

Tornadoes cause loss of life and damage to property each year in the United States and around the world. The largest impacts come from 'outbreaks' consisting of multiple tornadoes closely spaced in time. Here we find an upward trend...

Cite
Tippett MK, Cohen JE. Tornado outbreak variability follows Taylor's power law of fluctuation scaling and increases dramatically with severity. Nat Commun. 2016;7:10668doi: 10.1038/ncomms10668.
Tippett, M. K., & Cohen, J. E. (2016). Tornado outbreak variability follows Taylor's power law of fluctuation scaling and increases dramatically with severity. Nature communications, 710668. https://doi.org/10.1038/ncomms10668
Tippett, Michael K, and Cohen, Joel E. "Tornado outbreak variability follows Taylor's power law of fluctuation scaling and increases dramatically with severity." Nature communications vol. 7 (2016): 10668. doi: https://doi.org/10.1038/ncomms10668
Tippett MK, Cohen JE. Tornado outbreak variability follows Taylor's power law of fluctuation scaling and increases dramatically with severity. Nat Commun. 2016 Feb 29;7:10668. doi: 10.1038/ncomms10668. PMID: 26923210; PMCID: PMC4773447.
Copy Download .nbib Format: NLM
Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials.

Infectious diseases and therapy

Mehta DA, Cohen E, Charafeddine M, Cohen DE, Bao Y, Sanchez Gonzalez Y, Tran TT.
PMID: 28939957
Infect Dis Ther. 2017 Dec;6(4):515-529. doi: 10.1007/s40121-017-0171-0. Epub 2017 Sep 22.

INTRODUCTION: We analyzed phase 3 trial data of ombitasvir/paritaprevir/ritonavir and dasabuvir (3D) ± ribavirin (RBV) in genotype 1 chronic hepatitis C patients to investigate the impact of 3D ± RBV on renal, cardiovascular and metabolic extrahepatic manifestations (EHMs), including...

Cite
Mehta DA, Cohen E, Charafeddine M, et al. Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infect Dis Ther. 2017;6(4):515-529doi: 10.1007/s40121-017-0171-0.
Mehta, D. A., Cohen, E., Charafeddine, M., Cohen, D. E., Bao, Y., Sanchez Gonzalez, Y., & Tran, T. T. (2017). Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infectious diseases and therapy, 6(4), 515-529. https://doi.org/10.1007/s40121-017-0171-0
Mehta, Darshan A, et al. "Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials." Infectious diseases and therapy vol. 6,4 (2017): 515-529. doi: https://doi.org/10.1007/s40121-017-0171-0
Mehta DA, Cohen E, Charafeddine M, Cohen DE, Bao Y, Sanchez Gonzalez Y, Tran TT. Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials. Infect Dis Ther. 2017 Dec;6(4):515-529. doi: 10.1007/s40121-017-0171-0. Epub 2017 Sep 22. PMID: 28939957; PMCID: PMC5700891.
Copy Download .nbib Format: NLM
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.

Annals of oncology : official journal of the European Society for Medical Oncology

O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA.
PMID: 26945010
Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 03.

No abstract available.

Cite
O'Neil BH, Scott AJ, Ma WW, et al. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol. 2016;27(6):1180doi: 10.1093/annonc/mdw095.
O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Aisner, D. L., Menter, A. R., Tejani, M. A., Cho, J. K., Granfortuna, J., Coveler, A. L., Olowokure, O. O., Baranda, J. C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D. J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A. J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C. L., & Messersmith, W. A. (2016). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 27(6), 1180. https://doi.org/10.1093/annonc/mdw095
O'Neil, B H, et al. "A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer." Annals of oncology : official journal of the European Society for Medical Oncology vol. 27,6 (2016): 1180. doi: https://doi.org/10.1093/annonc/mdw095
O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler AL, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Boles J, Nazemzadeh R, Rarick M, Cohen DJ, Radford J, Fehrenbacher L, Bajaj R, Bathini V, Fanta P, Berlin J, McRee AJ, Maguire R, Wilhelm F, Maniar M, Jimeno A, Gomes CL, Messersmith WA. A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Ann Oncol. 2016 Jun;27(6):1180. doi: 10.1093/annonc/mdw095. Epub 2016 Mar 03. PMID: 26945010; PMCID: PMC6795379.
Copy Download .nbib Format: NLM
Editorial comment: health-related quality of life in hemodialysis patients: an Iranian multi-center study.

Nephro-urology monthly

Nobakht E, Cohen SD.
PMID: 25032131
Nephrourol Mon. 2014 Mar 09;6(2):e16986. doi: 10.5812/numonthly.16986. eCollection 2014 Mar.

No abstract available.

Cite
Nobakht E, Cohen SD. Editorial comment: health-related quality of life in hemodialysis patients: an Iranian multi-center study. Nephrourol Mon. 2014;6(2):e16986doi: 10.5812/numonthly.16986.
Nobakht, E., & Cohen, S. D. (2014). Editorial comment: health-related quality of life in hemodialysis patients: an Iranian multi-center study. Nephro-urology monthly, 6(2), e16986. https://doi.org/10.5812/numonthly.16986
Nobakht, Ehsan, and Cohen, Scott D. "Editorial comment: health-related quality of life in hemodialysis patients: an Iranian multi-center study." Nephro-urology monthly vol. 6,2 (2014): e16986. doi: https://doi.org/10.5812/numonthly.16986
Nobakht E, Cohen SD. Editorial comment: health-related quality of life in hemodialysis patients: an Iranian multi-center study. Nephrourol Mon. 2014 Mar 09;6(2):e16986. doi: 10.5812/numonthly.16986. eCollection 2014 Mar. PMID: 25032131; PMCID: PMC4090582.
Copy Download .nbib Format: NLM
Localization of vascular endothelial growth factor in nontumorous human pituitaries.

Endocrine pathology

Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW.
PMID: 27519215
Endocr Pathol. 1999 Jun;10(2):109-22. doi: 10.1007/BF02739823.

Vascular endothelial growth factor (VEGF) is a key mediator of endothelial cell proliferation, angiogenesis, and vascular permeability. Our aim was to investigate whether VEGF is expressed in various cell types of the human pituitary. Eight nontumorous pituitaries were investigated...

Cite
Vidal S, Kovacs K, Cohen SM, et al. Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocr Pathol. 1999;10(2):109-22doi: 10.1007/BF02739823.
Vidal, S., Kovacs, K., Cohen, S. M., Stefaneanu, L., Lloyd, R. V., & Scheithauer, B. W. (1999). Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocrine pathology, 10(2), 109-22. https://doi.org/10.1007/BF02739823
Vidal, S, et al. "Localization of vascular endothelial growth factor in nontumorous human pituitaries." Endocrine pathology vol. 10,2 (1999): 109-22. doi: https://doi.org/10.1007/BF02739823
Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW. Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocr Pathol. 1999 Jun;10(2):109-22. doi: 10.1007/BF02739823. PMID: 27519215.
Copy Download .nbib Format: NLM
Connecting qualitative research on exercise and environment to public health agendas requires an equity lens.

Health & place

Coen SE.
PMID: 29150314
Health Place. 2018 Sep;53:264-267. doi: 10.1016/j.healthplace.2017.09.005. Epub 2017 Nov 15.

In this commentary, I respond to the special section in Health & Place (vol. 46) on "Exercise and environment: new qualitative work to link popular practice and public health" edited by Hitchings and Latham. I argue that if qualitative...

Cite
Coen SE. Connecting qualitative research on exercise and environment to public health agendas requires an equity lens. Health Place. 2017;53:264-267doi: 10.1016/j.healthplace.2017.09.005.
Coen, S. E. (2018). Connecting qualitative research on exercise and environment to public health agendas requires an equity lens. Health & place, 53264-267. https://doi.org/10.1016/j.healthplace.2017.09.005
Coen, Stephanie E. "Connecting qualitative research on exercise and environment to public health agendas requires an equity lens." Health & place vol. 53 (2018): 264-267. doi: https://doi.org/10.1016/j.healthplace.2017.09.005
Coen SE. Connecting qualitative research on exercise and environment to public health agendas requires an equity lens. Health Place. 2018 Sep;53:264-267. doi: 10.1016/j.healthplace.2017.09.005. Epub 2017 Nov 15. PMID: 29150314.
Copy Download .nbib Format: NLM
Patents and literature.

Applied biochemistry and biotechnology

Kit M, Narasimhan MJ, Anderson JA, Zimmermann U, Pilwat G, Furuya T, Tani Y, Kolehmainen SE, Tarkkanen V, Barrett SP, Gestrelius SM, Belloc A, Florent J, Lunel J, Palla J, Mancy D, Bailey JE, Cho YK, Mouri T, Kayama H, Foley SE, Oriel PJ, Epstein CC, Kimura K, Spraker PW, Ljungdahl LG, Wieget JK, Levine DW, Thilly WG, Wang DI, Wong JS, Eisinger MG, Young FE, Wilson GA, Mottice SL, Green H, Kehinde O, Buhler M, Olofsson M, Osseux PF, Degen L, Branduzzi P, Olivieri R, Cimini N, Kang KS, Veeder GT, Latymer Z, Andersen G, Drobot W, Monsheimer R, Pfleiderer E, Hidaka H, Kohno T, Eida T, Weisrock WP, Stevens VC, Takezawa K, Hiratani H, Wandrey C, Wichmann R, Leuchtenberger W, Kula M, Buckmann A, Troller J, Koshugi J, Frommer W, Muller L, Schmidt D, Puls W, Krause H, Heber U, Cohen SN, Wahl GM, Stark GR, Collins J, Hohn B, Sugano H, Matsui Y.
PMID: 24234232
Appl Biochem Biotechnol. 1982 May;7(3):217-30. doi: 10.1007/BF02798299.

No abstract available.

Cite
Kit M, Narasimhan MJ, Anderson JA, et al. Patents and literature. Appl Biochem Biotechnol. 1982;7(3):217-30doi: 10.1007/BF02798299.
Kit, M., Narasimhan, M. J., Anderson, J. A., Zimmermann, U., Pilwat, G., Furuya, T., Tani, Y., Kolehmainen, S. E., Tarkkanen, V., Barrett, S. P., Gestrelius, S. M., Belloc, A., Florent, J., Lunel, J., Palla, J., Mancy, D., Bailey, J. E., Cho, Y. K., Mouri, T., Kayama, H., Foley, S. E., Oriel, P. J., Epstein, C. C., Kimura, K., Spraker, P. W., Ljungdahl, L. G., Wieget, J. K., Levine, D. W., Thilly, W. G., Wang, D. I., Wong, J. S., Eisinger, M. G., Young, F. E., Wilson, G. A., Mottice, S. L., Green, H., Kehinde, O., Buhler, M., Olofsson, M., Osseux, P. F., Degen, L., Branduzzi, P., Olivieri, R., Cimini, N., Kang, K. S., Veeder, G. T., Latymer, Z., Andersen, G., Drobot, W., Monsheimer, R., Pfleiderer, E., Hidaka, H., Kohno, T., Eida, T., Weisrock, W. P., Stevens, V. C., Takezawa, K., Hiratani, H., Wandrey, C., Wichmann, R., Leuchtenberger, W., Kula, M., Buckmann, A., Troller, J., Koshugi, J., Frommer, W., Muller, L., Schmidt, D., Puls, W., Krause, H., Heber, U., Cohen, S. N., Wahl, G. M., Stark, G. R., Collins, J., Hohn, B., Sugano, H., & Matsui, Y. (1982). Patents and literature. Applied biochemistry and biotechnology, 7(3), 217-30. https://doi.org/10.1007/BF02798299
Kit, M, et al. "Patents and literature." Applied biochemistry and biotechnology vol. 7,3 (1982): 217-30. doi: https://doi.org/10.1007/BF02798299
Kit M, Narasimhan MJ, Anderson JA, Zimmermann U, Pilwat G, Furuya T, Tani Y, Kolehmainen SE, Tarkkanen V, Barrett SP, Gestrelius SM, Belloc A, Florent J, Lunel J, Palla J, Mancy D, Bailey JE, Cho YK, Mouri T, Kayama H, Foley SE, Oriel PJ, Epstein CC, Kimura K, Spraker PW, Ljungdahl LG, Wieget JK, Levine DW, Thilly WG, Wang DI, Wong JS, Eisinger MG, Young FE, Wilson GA, Mottice SL, Green H, Kehinde O, Buhler M, Olofsson M, Osseux PF, Degen L, Branduzzi P, Olivieri R, Cimini N, Kang KS, Veeder GT, Latymer Z, Andersen G, Drobot W, Monsheimer R, Pfleiderer E, Hidaka H, Kohno T, Eida T, Weisrock WP, Stevens VC, Takezawa K, Hiratani H, Wandrey C, Wichmann R, Leuchtenberger W, Kula M, Buckmann A, Troller J, Koshugi J, Frommer W, Muller L, Schmidt D, Puls W, Krause H, Heber U, Cohen SN, Wahl GM, Stark GR, Collins J, Hohn B, Sugano H, Matsui Y. Patents and literature. Appl Biochem Biotechnol. 1982 May;7(3):217-30. doi: 10.1007/BF02798299. PMID: 24234232.
Copy Download .nbib Format: NLM
Spatiotemporal Discordance in Five Common Measures of Rurality for US Counties and Applications for Health Disparities Research in Older Adults.

Frontiers in public health

Cohen SA, Kelley L, Bell AE.
PMID: 26636064
Front Public Health. 2015 Nov 25;3:267. doi: 10.3389/fpubh.2015.00267. eCollection 2015.

INTRODUCTION: Rural populations face numerous barriers to health, including poorer health care infrastructure, access to care, and other sociodemographic factors largely associated with rurality. Multiple measures of rurality used in the biomedical and public health literature can help assess...

Cite
Cohen SA, Kelley L, Bell AE. Spatiotemporal Discordance in Five Common Measures of Rurality for US Counties and Applications for Health Disparities Research in Older Adults. Front Public Health. 2015;3:267doi: 10.3389/fpubh.2015.00267.
Cohen, S. A., Kelley, L., & Bell, A. E. (2015). Spatiotemporal Discordance in Five Common Measures of Rurality for US Counties and Applications for Health Disparities Research in Older Adults. Frontiers in public health, 3267. https://doi.org/10.3389/fpubh.2015.00267
Cohen, Steven A, et al. "Spatiotemporal Discordance in Five Common Measures of Rurality for US Counties and Applications for Health Disparities Research in Older Adults." Frontiers in public health vol. 3 (2015): 267. doi: https://doi.org/10.3389/fpubh.2015.00267
Cohen SA, Kelley L, Bell AE. Spatiotemporal Discordance in Five Common Measures of Rurality for US Counties and Applications for Health Disparities Research in Older Adults. Front Public Health. 2015 Nov 25;3:267. doi: 10.3389/fpubh.2015.00267. eCollection 2015. PMID: 26636064; PMCID: PMC4658471.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 906 entries